Loading profile…
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
DBA: N/A
EIN 92-1746571 · Snapshot of IRS recognition, filing currency, financial health, and governance.
Secure the sustained appropriations and policies necessary to further enable NCATS to lead the transformation and acceleration of translational science research and development to diagnose, treat and cure rare and common diseases; and to educate policymakers, medical professionals, the medical industry, patients, and other stakeholders about the nature and vital role of NCATS in translational sciences research and development in improving our health and well-being.
Principal Officer
Kevin Brennan
Total Revenue
$53K
FY2024
Total Expenses
$36K
FY2024
Net Assets
$16K
Program Ratio
99.7%
expenses on programs
Employees
—
Volunteers
—
Board Members
—
Voting
—
Independent
8 answers compiled from IRS Form 990, BMF, Pub 78, and the Auto-Revocation List.